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Abstract
Expressing proteins of interest as fusions to proteins of the bacterial envelope is a powerful
technique with many biotechnological and medical applications. Autotransporters have recently
emerged as a good tool for bacterial surface display. These proteins are composed of an N-terminal
signal peptide, followed by a passenger domain and a translocator domain that mediates the outer
membrane translocation of the passenger. The natural passenger domain of autotransporters can
be replaced by heterologous proteins that become displayed at the bacterial surface by the
translocator domain. The simplicity and versatility of this system has made it very attractive and it
has been used to display functional enzymes, vaccine antigens as well as polypeptides libraries. The
recent advances in the study of the translocation mechanism of autotransporters have raised
several controversial issues with implications for their use as display systems. These issues include
the requirement for the displayed polypeptides to remain in a translocation-competent state in the
periplasm, the requirement for specific signal sequences and "autochaperone" domains, and the
influence of the genetic background of the expression host strain. It is therefore important to
better understand the mechanism of translocation of autotransporters in order to employ them to
their full potential. This review will focus on the recent advances in the study of the translocation
mechanism of autotransporters and describe practical considerations regarding their use for
bacterial surface display.
Review
Introduction
The display of proteins on the surface of biological organ-
isms is of major interest in biotechnology and medicine.
Several techniques have been developed to display
polypeptides on the surface of viruses, yeast or bacteria
[1]. Bacterial surface display has found many applications
in recent years [1,2]. Displaying single or multiple
epitopes, as well as complete proteins, on the bacterial
surface can for instance yield recombinant vaccines that
can possibly be taken orally [3]. Such recombinant bacte-
ria can also be used for the production of antigens or anti-
bodies necessary in the design of diagnostic tools. In
another application, bacteria can be engineered to display
functional recombinant enzymes at their surfaces and can
thus be used as "biofactories", with many biotechnologi-
cal applications [4-6]. In a variation of this principle, the
use of bacterial hosts that can resist various types of pollu-
tion and have been engineered to display proteins able to
fix heavy metals has been applied to the design of new
bioremediation approaches [7]. Lastly, bacterial surface
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ing of peptides and enzymes libraries [8,9].
Surface display consists in genetically fusing a protein of
interest to another protein that will allow its presentation
at the surface of an organism [1]. Bacterial display thus
exploits a mechanism that mediates the export of the pro-
tein of interest from the cytoplasm to the surface [2]. Both
Gram-positive and Gram-negative bacteria might be used
for surface display [10]. Gram-negative bacteria, however,
possess two membranes that proteins need to cross in
order to reach the extracellular milieu and these bacteria
resort to different secretion systems to target proteins to
their surface. Most bacterial proteins that are exported
across the inner membrane use either the general secre-
tion (sec) or the twin arginine translocation (tat) pathways
[11,12]. From the periplasm, integral outer membrane
proteins (OMP) are then inserted, either spontaneously,
or using a specialized machinery comprising the protein
Omp85 [13] and other envelope proteins [14]. LamB [15]
and OmpA [16] were the first OMPs to be used for bacte-
rial surface display in Escherichia coli but since then, many
more have been employed, including PhoE [17], OmpC
[18], TraT [19], FhuA [20], or intimin [21]. Some surface
exposed outer membrane lipoproteins have also been
used for bacteria surface display, such as the ice nucleation
protein of Pseudomonas syringae [22]. From precursors in
the periplasm, Gram-negative bacteria also assemble com-
plex structures at their surfaces, such as flagella, pili or S-
layers, all of which have been used for display of proteins
or peptides [23-25]. Lastly, several dedicated protein
secretion system in Gram-negative bacteria allow the sur-
face anchoring of the proteins they transport [26]. Some
of these systems have been used for the display of pro-
teins. This is the case, for instance, with the type II secre-
tion system. The type II secretion system, also called the
main terminal branch of the sec pathway, permits the
translocation in the extracellular medium of proteins
exported in the periplasm by the sec or tat pathway [27].
This complex machinery comprises at least a dozen pro-
teins situated in the inner membrane, the periplasm and
the outer membrane. One substrate of a type II secretion
system, the enzyme pullulanase from Klebsiella oxytoca was
used to display the periplasmic enzyme β-lactamase on
the surface of E. coli [28]. The type III secretion system has
also been used as a display system. This system is geneti-
cally and structurally analogous to the flagellum and com-
prises up to 20 different proteins found in each layer of
the bacterial envelope [29]. The system functions as a
molecular syringe delivering bacterial virulence proteins
from the bacterial cytoplasm directly into the extracellular
milieu or the cytosol of plant or animal cells. The main
structural component of the type III secretion system of E.
coli, EspA, has recently been used as a display system for
short polypeptides [30]. But the most widely used secre-
tion system for bacterial surface display has been the type
V secretion system and more specifically the subgroup of
monomeric autotransporters (AT) [31].
Autotransporters
The first AT discovered was the Neisseria gonorrhoeae IgA
protease [32] and the term 'autotransporters' was coined
when it was realized that more proteins exhibited the sim-
ilar striking feature of being translocated from the peri-
plasm across the outer membrane as a single polypeptide
that contained all the information necessary for secretion
[33]. Since then, many AT have been identified. Most are
involved in the virulence of bacterial pathogens and take
part in various processes such as adhesion, aggregation,
invasion, biofilm formation, serum resistance and cyto-
toxicity [31]. AT belong to the type V secretion system of
which they constitute the type Va branch [31]. Similar
proteins, initially grouped with the IgA proteases, were
subsequently found to require trimerization in order to
promote their secretion [34-36]. Hence, these proteins
form the trimeric autotransporters group [37], or type Vc
branch of the type V secretion system [31]. Lastly, the two-
partner secretion system (TPS) is closely related to AT.
Whereas AT are single polypeptides that contain two
domains, one which is secreted across the outer mem-
brane and another one which mediates this translocation
step, in TPS systems the two domains are synthesized as
two independent polypeptides [38]. TPS constitute the
type Vb branch of the type V secretion system [31]. TPS
and trimeric autotransporters have seldom been used for
bacterial surface display and mostly for the purpose of
translocation studies [34]. They will therefore not be dis-
cussed further.
Autotransporters share a distinctive organization in three
main domains (Figure 1A, [32]). At their N terminus they
have a sec-dependent signal peptide followed by a passen-
ger domain comprising the functional part of the protein.
This passenger domain is translocated through the outer
membrane thanks to a C-terminal region called the trans-
location unit (TU). TU are composed of two sub domains:
the C-terminal 250 to 300 aminoacids that are predicted
to form a β-barrel inserted in the outer membrane [39,40]
and, immediately before that, a 25 aminoacids linker
region predicted to adopt an α-helical conformation
[41,42]. The extracellular part of the AT, the passenger
domain, has also two sub domains: an N-terminal
domain that bears the activity of the AT and a C-terminal
domain called the autochaperone domain [43]. This auto-
chaperone domain is dispensable for translocation but
increases its efficiency, either by stabilizing the β-barrel
[44], or by promoting the folding of the passenger
domain [43,45,46].Page 2 of 15
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served among the different AT and to contain four steps:
(i) inner membrane translocation, (ii) periplasmic trans-
port, (iii) insertion into and translocation across the outer
membrane, and (iv) processing of the passenger domain
(Figure 1B).
a) Translocation across the inner membrane
Autotransporters exhibit an N-terminal sequence bearing
most of the typical features of sec-dependent signal pep-
tides [11]. But some AT, such as the group of serine pro-
teases autotransporters of Enterobacteriaceae (SPATEs),
have an unusually long signal peptide [47]. The long pep-
tide signal sequences have a conserved domain structure,
bearing an N-terminal extension which has a relatively
conserved sequence, whereas the other domains of the
Organization and biogenesis of autotransportersFigure 1
Organization and biogenesis of autotransporters. A. The typical organization of an autotransporter (AT) comprising an 
N-terminal signal sequence (SS), a passenger domain and a translocation unit (TU). The passenger domain includes an N-termi-
nal part that bears the activity of the AT and a C-terminal domain, called the autochaperone domain, which is important for 
efficient translocation across the outer membrane. The TU also has two distinct domains; the N-terminal region is structured 
as an α-helix, whereas the C-terminal region is structured as a β-barrel. B. The biogenesis of an AT has four main steps: trans-
location across the inner membrane, periplasmic transport, insertion into and translocation across the outer membrane and, 
lastly, processing of the passenger domain.
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in some trimeric autotransporters, such as the Haemo-
philus influenzae Hsf and Hia adhesins [48,49], and some
TPS systems, such as the H. influenzae HMW adhesins and
the Bordetella pertussis filamentous haemagglutinin
[50,51].
Despite this puzzling characteristic, little attention was
devoted to the mechanism of transport across the inner
membrane. Two main targeting pathways to the sec
machinery co-exist in bacteria: The SecB protein targets
bacterial protein post-translationally whereas the signal
recognition particle (SRP) targets bacterial proteins co-
translationally to the sec translocon, via its membrane
receptor FtsY [52]. A report showed that the targeting to
the sec machinery of the E. coli haemoglobin protease,
which possesses an unusually long signal peptide, was
mediated by SRP [53]. In this report, it was shown that the
extended signal sequence can strongly be cross-linked to
SRP in vitro [53]. Depletion of the SRP pathway, however,
had only a moderate but significant effect in vivo on the
efficacy of the protease secretion [53]. In another study,
when the extension of the unusually long signal sequence
of the E. coli AT EspP was removed the resulting truncated
signal sequence allowed interaction with SRP [54]. These
results therefore suggested that AT, and possibly even
those without unusual long signal sequence, might be
crossing the inner membrane co-translationally, presum-
ably to avoid adverse effects the cytoplasm might exert on
their passenger domain. But another report challenged
this view by showing that the secretion of the Shigella
flexneri AT IcsA, which also bears an unusually long signal
peptide, is independent of the SRP pathway [55]. This
study did confirm, however, that IcsA crosses the mem-
brane via the sec machinery [55]. Furthermore, it was
reported that the extension of the unusually long signal
sequence was not required for crossing the inner mem-
brane [56]. More recently, it was shown that the full
length signal sequence of EspP does not interact with SRP
but instead recruits SecB [57], despite the fact that, as
mentioned above, the same group reported that the signal
sequence without the extension does interact with SRP
[54]. It was therefore hypothesized that the extension
might actually bypass SRP. Lastly, it could be noted that
the co-translational secretion model across the inner
membrane is hardly compatible with the fact that the E.
coli AT adhesin involved in diffuse adherence (AIDA-I) is
glycosylated by a cytoplasmic heptosyl-transferase [58]
In summary, the influence of the N-terminal extension on
the targeting to the sec machinery and the co-translational
versus post-translational nature of the targeting remain
controversial and will require further studies. Regardless
of the targeting mechanism, however, one study showed
that the role of the extension might be to cause a slow
down of the release from the sec machinery after translo-
cation in the periplasm [56]. It was proposed that this very
unusual property for a signal peptide might be required to
prevent misfolding of the passenger domain in the peri-
plasm [56]. This result awaits confirmation from other
independent studies.
b) Periplasmic transport
There are many lines of evidence suggesting that, after
crossing the inner membrane, the protein exists as a peri-
plasmic intermediate. Indeed, as discussed below, various
studies have shown that passenger domains can fold in
the periplasm and that this process is influenced by the
genetic factors of the host affecting the periplasmic envi-
ronment. These experiments therefore suggest that the
passenger domain of an AT has access to the periplasmic
environment before its translocation across the outer
membrane. Furthermore, a periplasmic intermediate was
isolated in the case of IcsA [59].
There is, however, a nagging controversy over the extent of
folding that the passenger domain of an AT undergoes
while in the periplasm. Most studies addressing the ques-
tion of passenger domain folding in the periplasm have
resorted to replacing original passenger domains with het-
erologous proteins [60-69]. The earliest experiments were
performed using the B subunit of the cholera toxin (CtxB)
fused to the TU of the Neisseria IgA protease. CtxB con-
tains cysteines that can become disulphide bonded in the
periplasm. It was initially shown that the outer membrane
translocation of CtxB is affected when it is able to form
disulphide bonds, and that the protein was blocked in the
periplasm [60,61]. Indeed, CtxB mutants without cysteine
were translocated more efficiently, and a similar effect was
observed when adding 2-mercaptoethanol in the growth
medium or when using dsbA mutant strains, conditions
that prevent the formation of disulphide bonds in the
periplasm [65]. Disulphide bond formation is a slow step
on the path of protein folding and the presence of such
bonds is often used as a marker for folding. These experi-
ments were therefore interpreted as indicative of an
incompatibility between periplasmic folding and outer
membrane translocation in AT. Thus, it was concluded
that the native passenger domains of AT must remain
unfolded in the periplasm. In other experiments, PhoA, a
periplasmic protein containing cysteines, was fused to the
TU of IcsA [63]. The translocation of PhoA across the bac-
terial outer membrane was incomplete and could be
increased when it was not allowed to form disulphide
bonds in the periplasm, confirming the results observed
with CtxB.
Recent studies, however, showed that single-chain anti-
body fragments (ScFv) fused to the TU of the Neisseria IgA
protease can be found in an active conformation on thePage 4 of 15
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necessary for most ScFv to adopt a correctly folded confor-
mation and it was shown that the disulphide bond could
be formed in the periplasm. Thus it was concluded that
the protein was folded prior to translocation, contradict-
ing the previous hypothesis. More experiments soon fol-
lowed, suggesting that polypeptides at least partially
folded could indeed be translocated across the outer
membrane. For instance, the native passenger domain of
IcsA was shown to contain a disulphide bond in the peri-
plasm prior to translocation [59]. Lastly, another study
using fusions between CtxB and the TU of EspP showed
that translocation of a passenger domain at least partially
folded was possible [69]. From these studies, one can pos-
tulate that the native passenger domains of AT might fold,
at least partly, in the periplasm.
All those experiments were performed using disulphide
bond formation as an indicator of folding, and by manip-
ulating the ability to form those bonds in order to assess
the effect of folding on translocation. The absence or pres-
ence of disulphide bonds, however, can not always corre-
late with the extent of folding of a protein [70,71]. The
number of aminoacids separating two bridged cysteines as
well as the propensity of the resulting loop to adopt a
structure will greatly influence the resulting shape of a
protein bearing a disulphide bridge. Furthermore, manip-
ulating the ability to form disulphide bonds by mutating
the cysteines of passenger domains or by changing the
periplasmic redox environment can have uncontrolled
effects on the protein via the induction of bacterial stress
responses [72]. This can complicate the interpretations of
studies resorting to the observation of the effects of disul-
phide bridges when their goal is to evaluate the impact of
folding on translocation. Indeed, it has been reported that
the precursor of OmpA can be translocated through the
sec machinery even in the presence of a disulphide bridge
[73], although it is accepted that the sec machinery exports
unfolded polypeptides. A recent study using MalE, a peri-
plasmic protein without cysteine, fused to the TU of
AIDA-I showed that the folding of the passenger domain
interferes with translocation by using MalE variants with
intrinsic folding defects [74].
Putting the published observations together, it seems
likely that the native passenger of AT can undergo some
folding in the periplasm but that the nature or the extent
of the folding of the native passenger domains is probably
limited. How can this controlled folding can happen in
the periplasm, and is there an involvement of periplasmic
chaperones in this process? These questions have hardly
been addressed. A recent study showed that the peptidyl-
prolyl isomerase FkpA might play a role in the secretion of
a ScFv fused to the TU of the Neisseria IgA protease [67].
Furthermore, as described above, the unusually long sig-
nal sequence of some AT might delay the dissociation
from the sec machinery, and therefore control periplasmic
folding [57].
The influence of many more periplasmic folding catalysts,
such as SurA or PpiA for instance [75], remain to be inves-
tigated. It will however be difficult to discriminate
between a contribution of these factors to the folding of
the TU and their role in the folding of the passenger
domain.
c) Insertion into and translocation across the outer membrane
Many different models have been proposed to describe
the insertion of an AT in the outer membrane [31], based
on the structural studies of the TU and passenger
domains, and on the observations regarding periplasmic
folding of the passenger domain described above. The
minimal requirement for translocation resides in the TU,
and in some AT the limits of the TU were experimentally
mapped [39,76]. The TU structure was predicted to consist
of an α-helix and a β-barrel [40-42]. Recently, the crystal
structure of the TU of the N. meningitidis AT NalP was
obtained [77], confirming earlier studies. The structure
consists in a twelve-stranded β-barrel and an α-helix
inserted in the β-barrel lumen with the N terminus of the
α-helix, which links to the passenger domain, localized at
the extracellular side of the outer membrane. It is interest-
ing to note that previous predictions have sometimes put
the α-helix partly inserted in the membrane rather than in
the lumen of the barrel [41]. The structure of the TU of
NalP shows numerous salt bridges between the helix and
the lumen of the barrel. In addition, it was observed that
barrel can form a pore, the conductance of which is
increased when the helix is absent, a finding that is con-
sistent with the structure of the helix partially blocking the
pore. These arguments tend to strengthen the validity of
the structure of the TU of NalP. It should be noted, how-
ever, first that the protein used to determine the structure
was obtained from inclusion bodies refolded in vitro, a
process that could influence the final structure, and sec-
ond that the limits of the TU of NalP were never experi-
mentally tested, i.e. it is not known whether the whole TU
is present in the structure solved.
Nevertheless, in the solved structure the dimension of the
pore of the β-barrel can be estimated at about 10 by 12.5
angströms and two conductance states of 0.15 or 1.3 nS
were recorded with the pure protein reconstituted in pla-
nar lipid bilayers [77]. Other studies have shown that the
TU of an AT can form pores in lipid bilayers [78], or in
liposomes [79,80]. These studies indicated the existence
of bigger-sized pores: the conductance of the TU of the B.
pertussis AT BrkA was estimated at about 3 nS [78], and the
size of the TU of the Neisseria IgA protease and of the Pseu-
domonas PalA were estimated at 2 nm [79,80].Page 5 of 15
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tures of some native AT passenger domains, and to the
studies on the folding state of the passenger domain in the
periplasm discussed above. Natural passenger domains of
AT are always polypeptides of at least 300 aminoacids and
the analysis of the sequences of many natural passenger
domains of AT suggested a preference towards β-strands
[81]. This prediction is confirmed by the structures of the
two AT passenger domains solved to date, that of B. pertus-
sis pertactin [82], and that of E. coli haemoglobin protease
[83]. Both structures share a similar fold consisting of an
extended right-handed parallel β-helix. This helix has a
cylindrical shape with a diameter of 20 to 30 angströms
and a length of 100 to 140 angströms. In both structures,
however, additional protruding loops or whole domains
considerably extend the diameter of the cylinder to sizes
up to 80 angströms.
As described above, the studies pertaining to the folding
state of the passenger domain have reached different con-
clusions and have been performed with heterologous pas-
senger domains. Some studies found that passenger
domains of even very small sizes, such as the 62 aminoac-
ids long aprotinin, could not be translocated folded [64],
other studies with passenger domains of 13 kDa (CtxB) or
30 kDa (ScFv) suggested that folded protein domains can
be translocated [67,69]. As stated above, the nature or the
extent of folding compatible with translocation is there-
fore still unclear. In this respect, it is striking to note the
conservation of the typical β-helical fold in the backbone
of passenger domains of AT. It is possible that this struc-
ture is uniquely adapted to the translocation mechanism.
Based on all these data, different models have been put
forward (Figure 2). In some models, the passenger
domain is thought to cross the outer membrane mostly
unfolded, through the lumen of the barrel. The small size
of the observed structure of the TU of NalP is consistent
with this hypothesis. According to this hypothesis, the
folding of the translocating polypeptide once it reaches
the extracellular milieu could also provide the energy for
translocation. Two models have been proposed based on
this hypothesis. One model suggests that the passenger
domain is translocated starting with its C terminus, the
autochaperone domain. This would result in the forma-
tion of a hairpin structure and thus the model was called
"hairpin model" ([32], Figure 2A). The NalP pore still
remains barely sufficient to accommodate two unfolded
polypeptides simultaneously. An alternative model sug-
gests that the passenger domain is translocated starting
with its N terminus. This model, called the "threading
model" ([77], Figure 2B), might alleviate the steric prob-
lem of the hairpin model because only one polypeptide
would be in the pore during translocation. However, this
model seems unlikely because it implies the recognition
of the N terminus by the TU, whereas unrelated heterolo-
gous passenger domain can also be translocated.
None of these models can take into account the transloca-
tion of even partially folded polypeptides because of the
narrow lumen of one β-barrel. Another model, a "mul-
timeric model" (Figure 2C), was proposed, based on the
observation that TUs of AT could form ring-like structures
visualized by electron microscopy [79]. The size of the
central cavity is large enough to allow translocation of
small folded proteins or protein domains. The multimeric
model therefore solves the steric problems of the hairpin
or threading models. This model, however, is inconsistent
with the structure of the TU of NalP for which no oli-
gomer was observed [77]. It is also inconsistent with the
observation that the α-helix, which is connected to the
passenger domain, is located inside the lumen of the β-
barrel and not outside, as the multimeric model would
predict [77]. Furthermore, if passenger domains are trans-
located folded, it is unclear what the energy source for the
translocation would be. Lastly, two studies have recently
demonstrated that the TU of AIDA-I and EspP are not
multimeric [69,84]. The oligomerization of the TU does
not therefore seem to be a common feature of AT.
As can be deduced from above, all the previous models
entail important steric and/or mechanistic problems. An
alternative model, called the "Omp85 model" ([77], Fig-
ure 2D), was therefore proposed. This model hypothesize
that translocation of AT involves Omp85, the protein that
promotes the insertion of integral outer membrane pro-
teins [13]. Since Omp85 is implicated in the insertion of
outer membrane proteins, some of which contain extra-
cellular loops representing up to half of the protein, it was
suggested that the same machinery could be involved in
the translocation of passenger domains. With this hypoth-
esis it is conceivable that some folded domains might be
accommodated and others rejected from translocation. It
is however difficult to differentiate the contribution of
Omp85 in the insertion of the TU and in the translocation
of the passenger domain.
In conclusion, the "Omp85 model" remains untested but
it is the model that seems to be the most favoured [69,77],
probably because it is the only one that could possibly
account for all the observations collected to date. Several
issues are still unresolved, though, and will need to be
addressed in future studies. First, the role of Omp85 in the
translocation of passenger domains will have to be rigor-
ously tested. In this respect, it will be important to deter-
mine if the translocation of passenger domain and the
insertion of the TU are performed in two separate steps or
in one single step. A related second question will be to
evaluate if the passenger domain uses the TU and/or
Omp85 as a translocation conduit. Trapping an interme-Page 6 of 15
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Mechanistic models of outer membrane translocation by autotransportersFigure 2
Mechanistic models of outer membrane translocation by autotransporters. A. Hairpin model: In this model the C-
terminal part of the passenger domain inserts itself as an unfolded polypeptide in the barrel of the TU, forming a hairpin. The 
extracellular folding of the autochaperone domain then pulls the remainder of the passenger domain. B. Threading model. This 
model is similar to the hairpin model but postulates that the N-terminal part of the passenger domain is inserted first, without 
hairpin. C. Multimeric model. In this model, multiple TUs are assembling in an oligomer forming a big central pore. Folded and 
unfolded polypeptides could then cross the outer membrane through this pore. D. Omp85 model. In this model, a number of 
periplasmic and outer membrane proteins organized around Omp85 are involved in the insertion of the TU and also the trans-
location across the outer membrane of the passenger domain.
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Microbial Cell Factories 2006, 5:22 http://www.microbialcellfactories.com/content/5/1/22diate in the translocation of an AT would be instrumental
in shedding some much needed light on these questions.
d) Modification and processing of the passenger domain
In many AT, the passenger domain is cleaved after trans-
location and the passenger domain is released in the extra-
cellular milieu. This is for instance the case of the SPATEs,
many of which act as extracellular toxins [85]. In some AT,
a part of the passenger domain can be cleaved and
released as a regulation mechanism. In this manner, the
amount of passenger domain found on the bacterial sur-
face, and hence the activity it confers, can be monitored.
This is for instance the case for the H. influenzae adhesin
Hap [86]. It is interesting to note in that case that the
cleavage can be influenced by host factors such as the
secretory leukocyte protease inhibitor [87]. A regulatory
cleavage was also shown to participate in the polar locali-
zation of IcsA [88]. In other AT, the passenger domain is
cleaved but remains non-covalently associated to the
outer membrane and the release of the cleaved fragment
is not detected under physiological conditions. This is for
instance the case of the E. coli AIDA-I adhesin [89]. The
role of the cleavage in those cases remains mysterious.
Lastly, some AT are not cleaved after translocation, such as
the E. coli TibA adhesin [90].
In many cases, the cleavage in the passenger domain is
thought to be autocatalytic. This has been peculiarly stud-
ied in the case of AT bearing a serine protease catalytic site.
In the case of the Hap adhesin, for example, the serine
protease catalytic site was shown to act in trans [91]. To
our knowledge, autoproteolysis in cis has not yet been
demonstrated. In some other cases, the cleavage might be
performed by an accessory outer membrane protease. This
is for instance the case with the protease SopA of S. flexneri
that cleaves IcsA [92], or with NalP, which is involved in
the processing of the Neisseria IgA protease [93]. In some
cleaved AT, however, no protease catalytic site has been
identified and no accessory protein has been found
responsible for their cleavage post-translocation. This is
the case, for example, of the E. coli AIDA-I adhesin [94].
Lastly, it should be noted that in some AT the passenger
domain can be lipidated [93,95,96] or glycosylated
[58,90,97].
Using autotransporters as a tool for surface display
As described above, bacterial surface display has found
many uses in the past few years. When it was realized that
they could efficiently present heterologous polypeptides
instead of native passenger domains to the bacterial sur-
face [60], AT quickly became interesting tools for bacterial
display. As shown in Table 1, they have successfully been
used for various purposes, including display of antigens
for vaccine purposes, display of enzymes and screening of
peptide libraries. Indeed, many features make AT an
attractive display system:
- Display of polypeptides of various sizes
AT can display small polypeptides, such as 10 to 15 ami-
noacids-long antigens for vaccines [68,98-100] or full size
proteins of up to 613 aminoacids, as in the case of the dis-
play of the Serratia marcescens lipase fused to EstA [101].
In addition, polypeptides displayed by AT were shown to
be able to oligomerize, a characteristic that allow dimeric
enzymes to be active [5,6], and which could possibly be
applied to display protein hetero-oligomers. This versatil-
ity contrasts with other systems that are restricted to
polypeptides of less than 100 aminoacids because of tox-
icity issues [104] or structural constraints, such as what
has been reported with display in fimbriae subunits [102]
or with the outer membrane protein LamB [103]. It
should be noted, however, that other systems have been
shown to display quite large proteins, such as the ice
nucleation protein or a phage display system, which were
shown to display protein of 424 aminoacids [22] or 471
aminoacids [105], respectively.
- Display of polypeptides as N-terminal fusions
In many bacterial display systems, such as flagellin or
pilin [102], some carrier proteins need their N and C ter-
mini to remain free in order to interact correctly with
other proteins promoting their export. Additionally, some
carrier integral outer membrane proteins have both N and
C termini located in the periplasm [103]. In both cases,
the display strategy therefore requires to insert foreign
proteins in permissive loops of these carriers, thus creat-
ing a so-called "sandwich fusion". Finding and character-
izing those sites is time-consuming and the use of one site
versus another might be insert-specific [24]. By contrast,
the polypeptides displayed by AT are fused to the N-termi-
nus of the TU, a situation which alleviate some of these
issues (although there are also reports of sandwich fusions
with AT [106]). It should be noted, however, that this sys-
tem is not amenable to the display of eukaryotic cDNA
libraries. Other bacterial display systems can be used for
the display of polypeptides as C-terminal fusions, such as
the E. coli outer membrane protein intimin [21] or the chi-
mera resulting from the fusion between parts of the E. coli
outer membrane proteins Lpp and OmpA [107].
- High level of expression and activity with little toxicity
In many cases it was noted that AT display allowed high
level of heterologous polypeptides presentation. The
enzyme β-lactamase, for instance, was expressed at higher
amounts when fused to the TU of the P. putida AT EstA,
than when it was fused to the ice nucleation protein [108].
The amount of the enzyme sorbitol dehydrogenase or of
bovine adrenodoxin fused to the TU of AIDA-I was also
found to be in excess over the major outer membranePage 8 of 15
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Table 1: Heterologous polypeptides fused to autotransporters and their surface display applications
Displayed polypeptides Translocatorc Application References
Name and origin Sizea Remarksb
CtxB, Vibrio cholerae 13 kDa 1 disulphide, Secreted EspP (E.coli), 450 aas/711 aas Translocation studies [69]
StxB, Shigella dysenteriae 7.7 kDa 1 disulphide, Secreted MisL (S. enterica), 505 aas/955 aas Vaccination [100]
Epitope, Plasmodium falciparum 32 aas No disulphide Vaccination [98, 100]
Aprotinin, bovine 62 aas 3 disulphides, 
Secreted
AIDA-I (E. coli), 440 aas/1287 aas Translocation studies [64]
OspG, Borellia burgdorferi 22 kDa Translocation studies [84]
Sorbitol dehydrogenase, Rhodobacter 
sphaeroides
29 kDa No disulphide, 
Cytoplasmic
Enzyme activity [5]
UreA, Helicobacter pylori 211 aas No disulphide, 
Cytoplasmic
Vaccination [99]
Epitope, Yersinia enterocolytica 16 aas No disulphide Vaccination [3]
Fragment of invasin, Mycobacterium 
tuberculosis
58 aas No disulphide Study of displayed 
protein
[113]
Adrenodoxin, bovine 14.4 
kDa
No disulphide, 
Secreted
Enzyme activity [6]
β- lactamase, bacterial 286 aas 1 disulphide, 
Periplasmic
Translocation studies [62]
LTB, Escherichia coli 11.6 
kDa
1 disulphide, Secreted Translocation studies [68]
CtxB, Vibrio cholerae 13 kDa 1 disulphide, Secreted Translocation studies [114]
Synthetic protease inhibitor 15 aas No disulphide Random screening [110]
MalE, Escherichia coli 366 aas No disulphide, 
Periplasmic
Translocation studies [74]
Lipase, Bacillus subtilis 181 aas Secreted EstA (P. aeruginosa), 686 aas/686 
aas
Enzyme activity [101]
Lipase, Fusarium solani 214 aas Secreted Enzyme activity [101]
Lipase, Serratia marcescens 613 aas Secreted Enzyme activity [101]
β- lactamase, bacterial 286 aas 1 disulphide, 
Periplasmic
EstA (P. putida), 325 aas/686 aas Translocation studies [108]
FimH lectin domain, Escherichia coli 177 aas 1 disulphide, Secreted, Ag43 (E. coli), 891 aas/1039 aas Translocation studies [106]
Various epitopes 12–14 
aas
No disulphide Ag43 (E. coli), 1039 aas/1039 aasd Vaccination [106]
MalE, Escherichia coli 366 aas No disulphide, 
Periplasmic
IcsA (S. flexneri), 338 aas/1102 
aas
Translocation studies [63]
PhoA, Escherichia coli 471 aas 2 disulphides, 
Periplasmic
Translocation studies [63]
Pseudo-azurin, Alcaligenes faecalis 123 aas No disulphide, 
Periplasmic
Ssp (S. marcescens), 356 aas/1045 
aas
Translocation studies [112]
Fos and Jun leucine zipper domains 8 kDa No disulphide, 
Intracellular
IgA protease (N. gonorrhoeae) Translocation studies [115]
Single-chain antibody (ScFv) 30 kDa 2 disulphides, 
Secreted
440 aas/1505 aas Translocation studies [66]
Single-chain antibody (ScFv) 30 kDa 2 disulphides, 
Secreted
Drug delivery [116]
CtxB, Vibrio cholerae 13 kDa 1 disulphide, 
Periplasmic
Translocation studies [60]
β- lactamase/trypsin inhibitor 314 aas 4 disulphide, 
Periplasmic
Random screening [9]
Metallothionein, murine 7 kDa No disulphide, 
Intracellular
Enzyme activity [7]
a: sizes are given as molecular weights (in Daltons) or as a number of aminoacids (aas); b: When known, the number of disulphide bridges normally 
found in the displayed polypeptides are indicated, as well as an indication of their original cellular localization. c: Unless otherwise indicated, all 
fusions were made to a C-terminal fragment of an AT, the name of the AT is provided, along with the bacterial species from which it originates and 
the lengths of the fragment and full length protein. d: The polypeptides were inserted as "sandwich fusions" in the full-length sequence of Ag43.
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cell [5,109]. A similar result was found with the display in
E. coli of CtxB fused to the TU of Neisseria IgA protease,
which was estimated to be about 50,000 copies per cell
[39]. Such high level of expression is desirable for some
applications, such as maximizing enzyme activity or using
fluorescence assisted cell sorting (FACS) [110], but it can
be a drawback when trying to screen libraries of binding
proteins, because low affinity clones will be enriched.
Despite such high levels of expression there is often very
little toxicity reported when using AT for display [66,108].
In cases where some toxicity was reported, it was not cor-
related with the size of displayed polypeptides [101]. It
should be noted, however, that high levels of toxicity have
sometimes been reported [9], and that it is also often
noted that reducing the temperature of growth enhances
the expression level or the activity of the displayed
polypeptides [62,108].
A drawback associated with the anchoring of enzymes to
the bacterial surface, however, is that the complexity of
the surface of bacteria, including their surface polysaccha-
rides, can become a barrier to the accessibility of the dis-
played enzymes to its substrates or impose structural
constraints resulting in lower specific activity [1]. In this
regard, AT have been shown to retain a significant portion
of the activity of displayed enzymes. It was for instance
observed that the specific activity of the enzyme β-lacta-
mase displayed when fused to the TU of AIDA-I was 20%
of that of purified free enzyme [62]. A similar finding was
reported with the display of sorbitol dehydrogenase [5].
Recently, instead of fusing the TU of AT to heterologous
passenger domains, polypeptides to be displayed have
also been fused to all or most of the passenger domains.
This was shown with the display of the adhesin FimH
fused to Ag43 [106] and with the display of lipases fused
to EstA [101]. In those cases, the passenger domain could
possibly act as a spacer that could keep the displayed
polypeptide away from the membrane and thus increase
specific activity, but this was not evaluated.
- Versatility
It is striking to note that one construct based on an AT
from one bacterial species can be used in different other
bacterial species. It has been for instance shown that the
same construct was displayed in E. coli and Salmonella or
Shigella [60,61,63,106], or in E. coli and Ralstonia eutropha
[7]. This is probably due to the fact that AT are found in
many different Gram-negative bacteria and that the over-
all topology of TU seems much conserved. It should be
noted, however, that the use of the TU of the Helicobacter
pylori AT VacA seems more restricted, as it was far less well
expressed in E. coli [111]
Because of all these features, AT appears to be peculiarly
well adapted tools for bacterial surface display. However,
as detailed above, the recent progress made in our under-
standing of the structure and function of AT highlights
important details to be considered when contemplating
the use of AT as display systems:
- Nature of the passenger domain
In various studies where the same translocator was used in
the same strain to display different heterologous passen-
gers, it was noted that the fusions achieved very different
yields of expression [62,101]. As described above, the
presence of cysteines able to form disulphide bonds has
often been reported to interfere with translocation
[60,63,65], and, more generally, the periplasmic folding
of a protein could interfere with its translocation [74]. If
the protein to be displayed contains cysteines, their loca-
tion in the protein should be considered. If cysteines are
close in the sequence of the protein, it is possible that the
formation of a disulphide bond does not require the pro-
tein to adopt an extended tertiary structure and therefore
does not affect translocation. However, translocation
often seems to be enhanced when the protein does not
contain any disulphide bond. Thus, one way to enhance
the translocation of cysteine-containing protein is to
change these residues by site-directed mutagenesis [60]. If
the cysteines cannot be replaced by other aminoacids, the
use of a dsbA- strain or the addition of 2-mercaptoethanol
in the growth medium has often been shown to enhance
the amount of proteins requiring a disulphide bridge that
can be displayed [7,61-63,65,108]. It should be noted,
however, that aprotinin, a protein that folds quickly and
which is stabilized by the presence of disulphide bonds,
could not be translocated by AIDA-I, even in a dsbA- back-
ground [64]. Translocation was only achieved in the pres-
ence of 2-mercaptoethanol [64]. Preventing disulphide
bond formation might however prevent the normal fold-
ing of the displayed protein or cause some toxicity.
Indeed, when β-lactamase fused to the TU of AIDA-I was
expressed in a dsbA- background it was significantly more
expressed, but there was twice more enzymatic activity in
the a dsbA+ background [62]. Similarly, the absence of
DsbA increased the amount of ScFv that could be dis-
played when fused to the TU of Neisseria IgA protease, but
the ScFv was only active when expressed in a dsbA+ context
[66]. Lastly, other features of the polypeptide to be dis-
played can cause potential problems, such as hydropho-
bicity or the presence of charges. The N terminus of UreA
was for instance deleted in order to be displayed in fusion
to the TU of AIDA-I because it contained lysine residues,
which might affect the secretion through the sec machin-
ery [99].Page 10 of 15
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Three approaches have been employed in this regard. A
first approach is the use of the native sec-dependent signal
sequence of the heterologous polypeptide, when the latter
is a periplasmic or secreted protein. This was for instance
the case in the display of CtxB, a periplasmic protein,
fused to the TU of Neisseria IgA protease [60], or for the
display of Alcaligenes faecalis pseudo-azurin, also a peri-
plasmic protein, fused to the TU of the Serratia serine pro-
tease [112]. A second approach is the use of the native
sequence signal of the passenger domain of the AT being
replaced. This was for instance the case in the display of a
fragment of a Mycobacterium tuberculosis invasin fused to
the TU of AIDA-I [113]. As stated above, some AT exhibit
peculiarly long signal sequences. Even though the role of
the latter is not definitely established, it seems to be nec-
essary for correct translocation, at least for native passen-
ger domains. When using the TU from an AT bearing a
long signal sequence it might therefore be necessary to
keep such a signal in order to optimize translocation effi-
ciency, but this was not tested. A third approach is the use
of the signal sequence of a periplasmic protein unrelated
to either the AT used for display or the heterologous
polypeptide displayed. A number of such signal sequences
have been used, for instance that of CtxB [5,99], PelB [7],
or PhoA [101].
- Length of the AT sequence used as a translocator
As stated above, the minimal part of the AT required for
translocation across the outer membrane is the TU, con-
sisting of the α-helix and the β-barrel. In practice, how-
ever, the precise limits of the α-helix have not been
structurally determined for any AT but NalP. Therefore,
most constructs used for display are probably leaving a
few aminoacids of the passenger domain in the final
hybrid. This might be of importance, since several studies
show that there is a wide variation in the efficacy of secre-
tion depending on the length of the AT passenger domain
left in the hybrid construct. In general, the more of the C-
terminal portion of the passenger domain is left in the
hybrid, the better is the expression level. This was
observed with the Neisseria IgA protease [39], IcsA [63],
AIDA-I [76] and EstA [108]. This was not strictly the case,
however, with the Serratia serine protease, where a hybrid
having a longer portion of the passenger domain was less
expressed than a hybrid with a shorter portion [112]. As
described above, the C-terminal part of the passenger
domain is the autochaperone region which was shown to
improve the secretion of native passenger domains
[43,45,46]. Since some studies argue that this effect is
mediated in part by interactions of the autochaperone
domain with the TU [44], keeping the autochaperone
domain in the construction of AT-based display vectors
might ensure optimal translocation efficiency. Addition-
ally, in some models, the autochaperone folding is
thought to provide the energy driving translocation [31],
another reason to keep these domains in display con-
structs. In some studies this issue has been completely
averted by displaying proteins as fusion to a full length
passenger domain, such as in the case of lipases fused to
EstA [101]. Interestingly, the display of the S. marcescens
lipase (613 aminoacids, making it, to our knowledge, the
longest protein displayed by an AT), used this system
[101].
- Release of the displayed polypeptide
As described above, in some AT the passenger domain
stays linked to the outer membrane whereas in others it is
cleaved and released in the extracellular milieu. Since in
most cases the passenger domain is replaced by the heter-
ologous polypeptide, the release is usually avoided for
lack of catalytic and/or cleavage site. However, even when
the autocatalytic release of the AT is prevented by a muta-
tion in the catalytic site or a replacement of the original
passenger domain by a heterologous polypeptide, resid-
ual release can be mediated by the outer membrane pro-
tease OmpT or other unknown proteases [61].
Consequently, the use of ompT- strains has been shown to
increase the expression level of polypeptides displayed by
AT [65,108,114]. Conversely, in the case where the pro-
tein of interest is to be released, the construct should bear
a cleavage site freely accessible and the protease responsi-
ble for the cleavage should be provided. This approach is
not always successful, however, probably because the
cleavage site can easily be masked by the heterologous
passenger domain [112].
- Host factors
As described above, depending on the presence or absence
of host factors such as DsbA or OmpT, a fusion to the TU
of an AT can yield vastly different levels of expression [62].
Similarly, the periplasmic proteases DegP and DegQ were
shown to degrade fusion partners to the TU of AIDA-I, but
the use of degP- or degQ- strains did not improve the dis-
play [64]. Lastly, it should be noted that the periplasmic
peptidyl-prolyl isomerase FkpA was found to increase the
efficiency of display of a ScFv or an isolated immunoglob-
ulin variable domain fused to the TU of Neisseria IgA pro-
tease [67]. The influence of more host factors need to be
addressed in future studies.
Conclusion
Using secretion systems or secreted proteins naturally
present in bacteria as tools for surface display of foreign
polypeptides represents an attractive prospect for many
biotechnological applications. However, the complexity
of most secretion systems and the structural constraints
bearing on secreted proteins can be a disadvantage. By
contrast, AT of Gram-negative bacteria stand out with
their simplicity and versatility. AT tolerate the replace-Page 11 of 15
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heterologous proteins, with apparently few constraints on
the nature of the polypeptides to be displayed. As our
understanding of the molecular mechanism of the bio-
genesis of AT gets more detailed, however, some new con-
siderations are emerging when considering these proteins
as display systems. First, folding of the polypeptide to be
displayed in the periplasm prior to translocation can have
some important effects on translocation, either because of
the size or the shape attained by the heterologous protein.
Second, the presence of AT-specific signal sequence and of
an autochaperone domain can also have dramatic conse-
quences on translocation. And third, it should be kept in
mind that many AT are cleaved after translocation and
released in the extracellular milieu. These considerations
should not be viewed as limitations of the AT display sys-
tem. Indeed, AT have already proven to be extremely effi-
cient as carrier proteins and it can be expected that, as our
understanding of these proteins grows, we will be able to
make the most out of their exploitation. In the future, we
can expect many important advances, such as the clarifica-
tion of the role of the unusually long signal sequences of
some AT, a better definition of the translocation mecha-
nism and the evaluation of the influence of periplasmic
and outer membrane proteins in the translocation proc-
ess. This will in turn allow the design of better constructs
with all the sequences of the AT that are important for effi-
cient secretion, and the selection of an optimized host.
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